CSPC Pharmaceutical Group Financial Overview
CSPC Pharmaceutical Group's market cap is currently $94.33B. The company's EPS TTM is HK$0.08831503760000001; its P/E ratio is 22.70; and it has a dividend yield of 2.93%. CSPC Pharmaceutical Group is scheduled to report earnings on November 20, 2025, and the estimated EPS forecast is HK$0.14. See an overview of income statement, balance sheet, and cash flow financials.
